We are live on ! Find out more
DNLI icon

Denali Therapeutics
DNLI

90 hedge funds and large institutions have $1.41B invested in Denali Therapeutics in 2018 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 13

57% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 21

15% more funds holding

Funds holding: 78 → 90 (+12)

1.09% more ownership

Funds ownership: 70.64% → 71.72% (+1.1%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

3% less capital invested

Capital invested by funds: $1.46B → $1.41B (-$49.1M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $2K

Holders
90
Holders Change
+12
Holders Change %
+15.38%
% of All Funds
2.01%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
25
Increased
33
Reduced
21
Closed
13
Calls
–
Puts
$2K
Net Calls
-$2K
Net Calls Change
-$9K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$31.3M
2
BlackRock
BlackRock
New York
+$23M
3
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$13.4M
4
State Street
State Street
Massachusetts
+$11.5M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$5.68M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$38.8M
2
Fidelity International
Fidelity International
Bermuda
-$25.2M
3
CM
Crestline Management
Texas
-$20.2M
4
FCMI
Foresite Capital Management II
California
-$5.43M
5
NTC
NF Trinity Capital
Hong Kong
-$2.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
26
Casdin Capital
New York
$2.07M +$1.81M +100,000 New
TA
27
Teachers Advisors
New York
$2.05M +$119K +6,541 +7%
Allianz Asset Management
28
Allianz Asset Management
Germany
$1.86M -$2.4M -132,076 -59%
Citigroup
29
Citigroup
New York
$1.84M +$1.39M +76,458 +595%
UBS Group
30
UBS Group
Switzerland
$1.62M +$1.26M +69,427 +766%
Wells Fargo
31
Wells Fargo
California
$1.54M +$94K +5,180 +7%
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$1.51M +$58.9K +3,245 +5%
TCIM
33
TIAA CREF Investment Management
New York
$1.45M -$48K -2,645 -4%
AllianceBernstein
34
AllianceBernstein
Tennessee
$1.43M +$308K +17,000 +32%
Goldman Sachs
35
Goldman Sachs
New York
$1.41M +$1.02M +56,100 +461%
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$1.26M +$412K +22,712 +60%
State of Wisconsin Investment Board
37
State of Wisconsin Investment Board
Wisconsin
$983K +$10.9K +600 +1%
WA
38
Wasatch Advisors
Utah
$941K -$249K -13,723 -23%
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$924K +$434K +23,900 +115%
CS
40
Credit Suisse
Switzerland
$910K +$330K +18,197 +70%
PFGIA
41
Patriot Financial Group Insurance Agency
Massachusetts
$899K -$42.1K -2,320 -5%
ProShare Advisors
42
ProShare Advisors
Maryland
$764K +$671K +36,985 New
AIG
43
American International Group
New York
$620K -$4.19K -231 -0.8%
Manulife (Manufacturers Life Insurance)
44
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$581K -$55.2K -3,042 -10%
Deutsche Bank
45
Deutsche Bank
Germany
$561K -$1.38M -76,228 -74%
P8IP
46
Pier 88 Investment Partners
California
$540K -$214K -11,800 -31%
TD Asset Management
47
TD Asset Management
Ontario, Canada
$473K +$9.07K +500 +2%
MIM
48
MetLife Investment Management
New Jersey
$432K – – –
MAM
49
Mark Asset Management
New York
$411K +$361K +19,900 New
UBS AM
50
UBS AM
Illinois
$409K +$92K +5,073 +35%
1
2
3 4 5

DNLI Hedge Fund Activity: Q4 2018 in Review

90 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Denali Therapeutics (DNLI) for Q4 2018, worth a combined $1.41B — down 3.4% from $1.46B a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new DNLI positions and 13 closed out — a net gain of 12 holders — while 33 added to existing stakes and 21 trimmed.

The largest buyer was Vanguard Group, adding an estimated $31.3M. The largest seller was Fidelity Investments, cutting an estimated $38.8M.

  • 90 institutional investors held Denali Therapeutics (DNLI) as of Q4 2018, up from 78 in Q3 2018.
  • Funds reported $1.41B of Denali Therapeutics stock for Q4 2018, down 3.4% quarter-over-quarter.
  • 25 funds opened new Denali Therapeutics positions in Q4 2018 and 13 closed out, a net change of +12 holders.
  • The largest Denali Therapeutics buyer in Q4 2018 was Vanguard Group, an estimated $31.3M added.
  • The largest Denali Therapeutics seller in Q4 2018 was Fidelity Investments, an estimated $38.8M sold.

Based on aggregated 13F filings for Q4 2018.